The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

Friday 24 October 2014
In today’s news, you may have read or heard about the drug olaparib receiving a recommendation from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use. Olaparib is one of several PARP inhibitor drugs that are currently being trialled, which reduce the ability of...
Annie Mulholland
Wednesday 8 October 2014
Inequalities in access to life-changing drugs have been a topic in the news this week. With limited treatment options for ovarian cancer, Target Ovarian Cancer has long been campaigning to ensure that women in England, Northern Ireland, Scotland and Wales can access those drugs that are showing a...
New drugs - new decisions
Wednesday 24 September 2014
Target Ovarian Cancer are actively campaigning for greater participation in clinical trials so we are pleased to inform you that over the last six months five trials have opened looking at the potential benefits of a new class of drugs called PARP inhibitors. Early small clinical trials (Phase I/II...
Friday 13 June 2014
There's been a lot happening in Wales on the cancer front of late. To start with the Welsh Assembly has been conducting an inquiry into progress of the implementation of their Cancer Delivery Plan 2008 to 2016. It’s led by the Health and Social Care Committee, whose members represent all the...